CS logo
small CS logo
Instytut Psychiatrii i Neurologii II Klinika Neurologiczna

Warszawa, Poland
Research institute in Warsaw
Jana III Sobieskiego 9, 02-957 Warszawa

About Instytut Psychiatrii i Neurologii II Klinika Neurologiczna


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Instytut Psychiatrii i Neurologii II Klinika Neurologiczna


During the past decade, Instytut Psychiatrii i Neurologii II Klinika Neurologiczna conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna" #1 collaborator was "ADIR, a Servier Group company" with 1 trials as a collaborator and "Sunovion" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Instytut Psychiatrii i Neurologii II Klinika Neurologiczna


According to Clinical.Site data, the most researched conditions in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna" are "Multiple Sclerosis" (4 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Relapsing Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Partial Epilepsy" (1 trials). Many other conditions were trialed in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna" in a lesser frequency.

Clinical Trials Intervention Types at Instytut Psychiatrii i Neurologii II Klinika Neurologiczna


Most popular intervention types in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (6 trials), "Placebo" (6 trials), "Fenebrutinib" (3 trials), "Antihistamine" (2 trials) and "Methylprednisolone" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Instytut Psychiatrii i Neurologii II Klinika Neurologiczna


The vast majority of trials in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna" are 11 trials for "All" genders.

Clinical Trials Status at Instytut Psychiatrii i Neurologii II Klinika Neurologiczna


Currently, there are NaN active trials in "Instytut Psychiatrii i Neurologii II Klinika Neurologiczna". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instytut Psychiatrii i Neurologii II Klinika Neurologiczna, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instytut Psychiatrii i Neurologii II Klinika Neurologiczna, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".